Category : Search result: Lilly Singh interview


Novo Nordisk launches Wegovy weight-loss pill in US

Novo Nordisk launches oral Wegovy weight-loss drug in the US, priced at $299. The pill, approved in Dec 2025, aims to regain market share from rival Eli Lilly. UK approval expected end-2026.

Evangeline Lilly reveals brain damage diagnosis

Marvel star Evangeline Lilly shares a traumatic brain injury diagnosis after a 2025 accident in Hawaii. She details her recovery journey and life reassessment. Read her full story.

Weight-Loss Pill Race in 2026: Lilly Leads Novo Nordisk

Novo Nordisk and Eli Lilly to launch oral GLP-1 drugs in 2026. Despite Novo's head start, analysts predict Lilly's market leadership in obesity and diabetes treatments will persist for years. Explore the details.

Martyrdom Day of Four Sahibzadas Observed Nationwide

The Sikh community solemnly observed the martyrdom day of the four Sahibzadas, the sons of Guru Gobind Singh Ji. Learn about the commemorations and the enduring legacy of their supreme sacrifice.

Page 1 of 4